HeartSciences (HSCSW) Equity Ratio (2022 - 2026)

HeartSciences has reported Equity Ratio for 5 years, with the latest figure at 0.35 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 12.07% year-over-year to 0.35; the trailing twelve-month figure through Jan 2026 stood at 0.35 (up 12.07% YoY), and the FY2025 full-year result was 0.05, down 93.69% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.35, down from 0.7 in the prior quarter.
• The five-year high for Equity Ratio was 0.8 in Q1 2024, with the low at 2.9 in Q2 2022.
• Historically, Equity Ratio has averaged 0.1 across 5 years, with a median of 0.33 in 2025.
• Annual changes were most pronounced in 2023 — Equity Ratio tumbled 406.93% — and 2024, when it jumped 1178.7%.
• HeartSciences' Equity Ratio stood at 0.23 in 2022, then plunged by 406.93% to 0.7 in 2023, then jumped by 174.15% to 0.52 in 2024, then jumped by 35.06% to 0.7 in 2025, then plunged by 49.67% to 0.35 in 2026.
• The last three Equity Ratio figures came in at 0.35 (Q1 2026), 0.7 (Q4 2025), and 0.49 (Q3 2025), per Business Quant data.